These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7080994)

  • 21. HLA antigens in adenocarcinoma of the digestive tract.
    Subirá ML; Crisci CD; Sanz ML; Voltas J; Zornoza G; Hernández JL; Oehling A
    Allergol Immunopathol (Madr); 1978; 6(6):527-34. PubMed ID: 752257
    [No Abstract]   [Full Text] [Related]  

  • 22. Immune responses in patients with carcinoma of the colorectum and stomach.
    House AK
    Cell Mol Biol Incl Cyto Enzymol; 1979; 24(4):313-8. PubMed ID: 387242
    [No Abstract]   [Full Text] [Related]  

  • 23. [Possible substances which block the rosette formation of peripheral lymphocyte Fc receptor to sensitized corpuscle (EA) in the serum of patients with gastric and colon cancer].
    Kaneko H
    Nihon Geka Gakkai Zasshi; 1983 Dec; 84(12):1259-68. PubMed ID: 6674781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer of the gastrointestinal tract results in a restricted T-cell repertoire dependent upon tumor differentiation.
    Luo W; Liao WJ; Huang YT; Shi M; Zhang Y; Wen Q; Zhou MQ; Ma L
    Cell Immunol; 2011; 270(1):47-52. PubMed ID: 21497799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Spontaneous rosette test in peptic ulcer of the stomach and stomach cancer].
    Ianeva M; Ianev P; Grigorov L
    Vutr Boles; 1978; 17(6):97-100. PubMed ID: 310602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced incidence of rectal cancer, compared to gastric and colonic cancer, in a population of 73,076 men and women chronically immunosuppressed.
    Stewart T; Henderson R; Grayson H; Opelz G
    Clin Cancer Res; 1997 Jan; 3(1):51-5. PubMed ID: 9815537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of cell-mediated immunity in long-term survivors of gastric or colorectal cancer.
    Machado IV; Ruíz Diez C; Blanca I; Bianco NE
    Am J Surg; 1984 Mar; 147(3):334-8. PubMed ID: 6608279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lymphocyte count in the blood of stomach cancer patients].
    Volodarskiĭ VL; Maslova MG; Gurina LI; Dybova TV
    Vestn Khir Im I I Grek; 1981 Feb; 126(2):23-7. PubMed ID: 6972117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preoperative immunochemotherapy for gastric cancer patients--immunomodulating effect of levamisole and lentinan on cell-mediated immunity and regional lymph node].
    Takeshita M; Kobori T; Sudo E; Miyamoto Y; Izuo M
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1052-60. PubMed ID: 7184439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunologic profile of patients with carcinoma of the colorectum in the aged].
    Melita P; Gorgone S; Labruto G; Belnome NA; Palmeri R; Liotta G
    Chir Ital; 1983 Oct; 35(5):623-33. PubMed ID: 6084562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in vitro migration inhibition of mononuclear cells in patients with colorectal carcinoma.
    Kowalczyk D; Zembala M; Popiela T; Labza H
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):435-9. PubMed ID: 749793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disturbance of cell-mediated immunity in patients with carcinoma of colon and rectum.
    Manousos ON; Economidou J; Pathouli C; Merikas G
    Gut; 1973 Sep; 14(9):739-42. PubMed ID: 4752038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunocompetence and its modification after BCG immunotherapy in patients with colon carcinoma.
    Pacheco-Rupil B; Depiante M; Yantorno C; Nuñez P; Casadio B
    Acta Gastroenterol Latinoam; 1980; 10(4):277-82. PubMed ID: 7270013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The relationship between selenium and immunity in large bowel cancer].
    Yu B; Wang M; Li D
    Zhonghua Wai Ke Za Zhi; 1996 Jan; 34(1):50-3. PubMed ID: 9275690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppressed blastformation of lymphocyte in cancer bearing patients, with special reference to the cancers of digestive tract.
    Orita K; Miwa H; Shinoda K; Tanaka S
    Acta Med Okayama; 1973 Apr; 27(1):37-41. PubMed ID: 4271876
    [No Abstract]   [Full Text] [Related]  

  • 36. Preoperative blastformation rate in gastrointestinal cancer patients.
    Miwa H; Orita K
    Acta Med Okayama; 1977 Aug; 31(4):257-62. PubMed ID: 145162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for existence of oligoclonal tumor-infiltrating lymphocytes and predominant production of T helper 1/T cytotoxic 1 type cytokines in gastric and colorectal tumors.
    Matsutani T; Shiiba K; Yoshioka T; Tsuruta Y; Suzuki R; Ochi T; Itoh T; Musha H; Mizoi T; Sasaki I
    Int J Oncol; 2004 Jul; 25(1):133-41. PubMed ID: 15201998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in cellular and humoral immunologic mechanisms in the postoperative period].
    Litarczek G; Tulbure D; Rădan A; Moţoiu I; Funduc I; Gayraud A; Oftez L; Dumitriu A
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1989; 38(1):69-80. PubMed ID: 2527384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunological studies of aging and the family in gastric cancer, with special reference to cell-medical immunity].
    Shigemoto M; Yokoyama I; Shibuya M
    Gan No Rinsho; 1987 Apr; 33(5 Suppl):522-6. PubMed ID: 3496472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunodeficiency in different histotypes of radically operable gastrointestinal cancers.
    Romano F; Uggeri F; Crippa S; Di Stefano G; Scotti M; Scaini A; Caprotti R; Uggeri F
    J Exp Clin Cancer Res; 2004 Jun; 23(2):195-200. PubMed ID: 15354402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.